» Articles » PMID: 3356708

Purification of a Skeletal Muscle Polypeptide Which Stimulates Choline Acetyltransferase Activity in Cultured Spinal Cord Neurons

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1988 Apr 25
PMID 3356708
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Extracts of rat skeletal muscle contain neurotrophic factors which stimulate the development of choline acetyltransferase in embryonic day 14 rat spinal cord cultures. The trophic activity does not bind heparin-Sepharose or lectin affinity columns. However, mild acid treatment separates the trophic activity into soluble and insoluble fractions. The acid-insoluble activity has been purified 5000-fold to apparent homogeneity using preparative sodium dodecyl sulfate gel electrophoresis to achieve final purification. The purified factor migrates as a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and isoelectric focusing, with an apparent molecular mass of 20 kDa and a pI of 4.8. The activity and apparent molecular weight of the purified factor are unaltered by treatment with reducing agents or incubation in acidic conditions. Activity, however, is destroyed by heating or protease treatment. Thus, the factor appears to be a single polypeptide without significant levels of glycosylation or charge microheterogeneity. These results represent the first purification of a neurotrophic factor from skeletal muscle. The physical properties and amino acid composition of this factor differ from those of nerve growth factor and heparin-binding growth factors, as well as from the neurotrophic factor from heart cell conditioned medium which induces cholinergic development in sympathetic neurons.

Citing Articles

Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse.

Yu J, Zhu H, Ko D, Kindy M Brain Res. 2008; 1238:143-53.

PMID: 18789909 PMC: 3275905. DOI: 10.1016/j.brainres.2008.08.053.


The cholinergic neuronal phenotype in Alzheimer's disease.

Blusztajn J, Berse B Metab Brain Dis. 2000; 15(1):45-64.

PMID: 10885540 DOI: 10.1007/BF02680013.


A femtomolar-acting neuroprotective peptide.

Brenneman D, Gozes I J Clin Invest. 1996; 97(10):2299-307.

PMID: 8636410 PMC: 507310. DOI: 10.1172/JCI118672.


Neuropeptides as growth and differentiation factors in general and VIP in particular.

Gozes I, Brenneman D J Mol Neurosci. 1993; 4(1):1-9.

PMID: 8318354 DOI: 10.1007/BF02736685.


Peripherin expression in hippocampal neurons induced by muscle soluble factor(s).

Djabali K, Zissopoulou A, de Hoop M, Georgatos S, Dotti C J Cell Biol. 1993; 123(5):1197-206.

PMID: 8245126 PMC: 2119872. DOI: 10.1083/jcb.123.5.1197.